Further to recent discussion on Depo Provera, my colleague
          in WHO's Special Programme of Research, Development and
          Research Training in Human Reproduction, Dr Heli Bathija,
          reports that <according to the research carried out by WHO
          in several countries, Depo Provera does not decrease the
          milk volume nor does it have any undesirable effect on
          baby's growth, health or development. In WHO studies the DP
          was usually administered at six weeks postpartum and then in
          three-month intervals>. For additional information, Heli is
          available on fax (41-22) 791-4171. She is not yet
          e-mailable.

          Jim Akre, Nutrition unit, WHO Geneva